BioClavis
Home News Conferences Customer Page FAQ'S
Enquiries
TempO-Seq TempO-Seq Workflow Resources Publications FAQs Detector Oligo Design Limitations of RNA-seq TempO-Span Patents
Panels TempO-Seq TempO-LINC FFPE TempO-Seq Blood Spot TempO-Seq miRNA TempO-Seq R Data Analysis Assays Collaborations
Pharma Academic research Clinical research Bioinformatics services Customer Page
Our story CSR Careers
Home TECHNOLOGY TempO-Seq TempO-Seq Workflow Resources Publications FAQs Detector Oligo Design Limitations of RNA-seq TempO-Span Patents Products Panels TempO-Seq TempO-LINC FFPE TempO-Seq Blood Spot TempO-Seq miRNA TempO-Seq R Data Analysis Assays Collaborations Services Pharma Academic research Clinical research Bioinformatics services Customer Page NewsConferences About Our story CSR Careers Customer PageFAQ'S
BioClavis
Enabling high-throughput transcriptomics using TempO-Seq
Enquiries
Revolutionizing Cancer Care: BRECISE Project Pioneers Precision Oncology
Ayokunmi AkanleMay 19, 2025
BioClavis advances single-cell genomics with launch of tempo-linc platform
Ayokunmi AkanleFebruary 26, 2024
BioClavis partner on newly launched RISK-HUNT3R project
Guest UserJune 24, 2021
BioClavis Win Rising Stars: High Growth Award at the 2021 Scotland's Life Sciences Awards
Guest UserMarch 25, 2021
Affordable and accurate barcode-style COVID-19 test could help open up workplaces by reassuring employers and staff
Guest UserDecember 19, 2020
Hours
Mon 9am - 6pm
Tue 9am - 6pm
Wed 9am - 6pm
Thu 9am - 6pm
Fri 9am - 6pm
BIOCLAVIS, LTD.

Carus House
201 Dumbarton Road
Clydebank, G81 4XJ
+44 (0) 141 286 5100
Contact
 
ABOUT

Our Story
CSR
Careers
TEMPO-SEQ

Overview
Resources
SERVICES

Pharma
Academic research
Clinical research
Sample submission
NEWS

EVENTS